MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Natera P/S Ratio 2011-2026 | NTRA
Annual P/S Ratio Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.47 | 13.5 | 20.6 | 8.15 | 3.28 | 2.68 | 2.06 | 1.18 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 | 1.18 | 7.24 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
6.64 | $ 113.25 | -1.38 % | $ 34.4 B |  USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 17.42 | -2.24 % | $ 928 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 16.35 | 0.28 % | $ 172 M |  China |
 |
Co-Diagnostics
CODX
|
9.4 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Danaher Corporation
DHR
|
6.09 | $ 189.05 | -1.58 % | $ 135 B | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
5.47 | $ 63.32 | 0.17 % | $ 24.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 166.89 | -0.79 % | $ 8.27 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 24.75 | 0.08 % | $ 687 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
1.29 | $ 14.37 | -6.48 % | $ 1.86 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 15.98 | -2.68 % | $ 483 M | USA |
 |
Guardant Health
GH
|
13.7 | $ 90.17 | 0.56 % | $ 11.3 B | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
0.718 | $ 2.61 | 0.58 % | $ 84.7 K | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 107.87 | -1.6 % | $ 8.9 B |  Irlanda |
 |
Illumina
ILMN
|
3.75 | $ 126.04 | -1.33 % | $ 20 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.13 | -1.84 % | $ 4.89 M | USA |
 |
BioNano Genomics
BNGO
|
0.279 | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 1.98 | 0.51 % | $ 8.76 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 271.93 | -0.96 % | $ 22.6 B | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 76.19 | 0.4 % | $ 5.14 B | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 501.47 | 1.1 % | $ 14.5 B | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.64 | -0.54 % | $ 430 M | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 7.9 | -1.5 % | $ 1.01 B | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.93 | 3.82 % | $ 2.15 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 198.9 | -0.08 % | $ 22.1 B | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 17.07 | -1.5 % | $ 382 M | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.71 | -0.74 % | $ 3.71 M | USA |
 |
Pacific Biosciences of California
PACB
|
3.11 | $ 1.42 | - | $ 426 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 26.78 | -1.58 % | $ 20 B | Niderland |
 |
Precipio
PRPO
|
1.6 | $ 26.03 | 0.19 % | $ 41.8 M | USA |
 |
Personalis
PSNL
|
3 | $ 6.03 | -8.36 % | $ 357 M | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |